4-((2-Bromo-4-(3,3,6,6-tetramethyl-1,8-dioxo-1,2,3,4,5,6,7,8,9,10-decahydroacridin-9-yl)phenoxy)methyl)benzoic acid

ID: ALA4171987

PubChem CID: 3333810

Max Phase: Preclinical

Molecular Formula: C31H32BrNO5

Molecular Weight: 578.50

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CC1(C)CC(=O)C2=C(C1)NC1=C(C(=O)CC(C)(C)C1)C2c1ccc(OCc2ccc(C(=O)O)cc2)c(Br)c1

Standard InChI:  InChI=1S/C31H32BrNO5/c1-30(2)12-21-27(23(34)14-30)26(28-22(33-21)13-31(3,4)15-24(28)35)19-9-10-25(20(32)11-19)38-16-17-5-7-18(8-6-17)29(36)37/h5-11,26,33H,12-16H2,1-4H3,(H,36,37)

Standard InChI Key:  GGYQEXHKGCVHOZ-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 38 42  0  0  0  0  0  0  0  0999 V2000
   10.1846   -5.3860    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.1834   -6.2055    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.8915   -6.6145    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.6011   -6.2051    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.5983   -5.3824    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.8897   -4.9771    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.4754   -6.6136    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.7680   -6.2044    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.4748   -7.4308    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   12.3045   -4.9711    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.0137   -5.3771    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   13.7199   -4.9658    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.4276   -5.3751    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.1332   -4.9646    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.1306   -4.1465    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.4164   -3.7407    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.7136   -4.1537    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.8362   -3.7343    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.2463   -2.9134    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.8270   -2.9167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.5373   -2.5097    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.5400   -1.6956    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.8340   -1.2823    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.1237   -1.6893    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.1193   -2.5095    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.2462   -3.7310    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.5424   -4.1389    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.5437   -4.9479    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.2473   -5.3552    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.9511   -4.9473    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.9514   -4.1321    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.8361   -5.3567    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   14.4109   -2.9168    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   14.4286   -6.1923    0.0000 Br  0  0  0  0  0  0  0  0  0  0  0  0
   15.4193   -0.5696    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.2365   -0.5696    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.7665   -4.9444    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.3538   -5.6502    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  2  7  1  0
  7  8  2  0
  7  9  1  0
  5 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 12  1  0
 15 18  1  0
 18 27  1  0
 18 20  1  0
 26 19  1  0
 19 21  1  0
 20 21  2  0
 20 25  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 26 27  2  0
 26 31  1  0
 27 28  1  0
 28 29  1  0
 29 30  1  0
 30 31  1  0
 28 32  2  0
 25 33  2  0
 13 34  1  0
 23 35  1  0
 23 36  1  0
 30 37  1  0
 30 38  1  0
M  END

Associated Targets(non-human)

GCN5 Histone acetyltransferase GCN5 (89 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 578.50Molecular Weight (Monoisotopic): 577.1464AlogP: 6.70#Rotatable Bonds: 5
Polar Surface Area: 92.70Molecular Species: ACIDHBA: 5HBD: 2
#RO5 Violations: 2HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): 2
CX Acidic pKa: 4.06CX Basic pKa: CX LogP: 5.57CX LogD: 2.45
Aromatic Rings: 2Heavy Atoms: 38QED Weighted: 0.41Np Likeness Score: -0.44

References

1. Xiong H, Han J, Wang J, Lu W, Wang C, Chen Y, Fulin Lian, Zhang N, Liu YC, Zhang C, Ding H, Jiang H, Lu W, Luo C, Zhou B..  (2018)  Discovery of 1,8-acridinedione derivatives as novel GCN5 inhibitors via high throughput screening.,  151  [PMID:29665527] [10.1016/j.ejmech.2018.02.005]

Source